Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?-Reference-Cited by-同舟云学术

Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?

Published:2024-01-30 Issue:3 Volume:41 Page:901-914
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Waitzberg Dan^ORCID,Guarner Francisco^ORCID,Hojsak Iva^ORCID,Ianiro Gianluca^ORCID,Polk D. Brent^ORCID,Sokol Harry^ORCID

Funder

Biocodex SAS

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12325-024-02783-3.pdf

Reference104 articles.

1. Perez NB, Dorsen C, Squires A. Dysbiosis of the gut microbiome: a concept analysis. J Holist Nurs. 2020;38(2):223–32.

2. Goldenberg JZ, Yap C, Lytvyn L, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017;12(12):CD006095.

3. Guo Q, Goldenberg JZ, Humphrey C, El Dib R, Johnston BC. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2019;4(4):CD004827.

4. McFarland LV. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis. 1998;16(5):292–307.

5. Neuman H, Forsythe P, Uzan A, Avni O, Koren O. Antibiotics in early life: dysbiosis and the damage done. FEMS Microbiol Rev. 2018;42(4):489–99.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PROBIÓTICOS NO TRATAMENTO DO MIELOMA MÚLTIPLO: UMA REVISÃO;RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218;2024-06-07